Drug
Ivig
Ivig: highest development phase Post-Market, developed by Grifols. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| IVIG NCT01179893 | Post-Market | Myasthenia Gravid |
| IVIG NCT00115778 | Phase 2 | Hypogammaglobulinemia |
Latest
No recent events.
Follow Ivig on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.